|
Hiley, C. R. Endocannabinoids and the Heart. J Cardiovasc Pharmacol (2009).
|
|
Amoros, I. et al. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. J Mol Cell Cardiol (2009).
|
|
Zuurman, L., Ippel, A. E., Moin, E. & van Gerven, J. M. Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol 67, 5-21 (2009).
|
|
Pacher, P. & Steffens, S. The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol (2009).
|
|
von Haehling, S., Lainscak, M., Springer, J. & Anker, S. D. Cardiac cachexia: A systematic overview. Pharmacol. Ther. (2008).
|
|
Sarzani, R. Endocannabinoids, blood pressure and the human heart. J. Neuroendocrinol. 20 Suppl 1, 58-62 (2008).
|
|
Montecucco, F., Burger, F., Mach, F. & Steffens, S. The CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol (2008).
|
|
Hajrasouliha, A. R. et al. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB(2) receptors in the rat heart. Eur. J. Pharmacol. 579, 246-252 (2008).
|